definiens: means ( a ) the patents and patent applications set forth in Exhibit A hereto or otherwise Controlled by [COMPANY] or any of its Affili ates as of the Effective Date and Covering any prod uct that contains a Compound as an active pharmaceutical ing redient ( alone or with other active ingredients ) in any forms, presentations, formulations or dosage streng ths, or any manufacture or use of the foregoing, ( b ) any patent or patent application Covering any product t hat contains a Compound as an active pharmaceutical ingredient ( alone or with other active ingredients ) in any forms, presentations, formulations or dosag e strengths, or any manufacture or use of the foregoing where th e patent or patent application Covers Know - How Cont rolled by [COMPANY] or any of its Affiliates and arises after the Effective Date and prior to the Cut - off Date ; ( c ) any patent application filed after the Effective Date on any o f the Licensed Know - How ; ( d ) any patent application s claiming priority to any of the foregoing, includin g continuations, divisionals, continuation - in - part and foreign patent applications, ( e ) all patents issuing from a ny of the foregoing patent applications described i n ( a ) through ( d ) ; and ( f ) all reissues, reexaminations, renewals, re - validations, re - registrations, patents of addi tion, supplementary patent certificates and extensions of any of the foregoing . Notwithstanding the foregoin g, the Licensed Patents do not include the Tarsus Patents